ENGAGE Intervention for Post-COVID Support in People With Disabilities
Trial Summary
What is the purpose of this trial?
This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the idea that ENGAGE Intervention for Post-COVID Support in People With Disabilities (also known as: ENGAGE) is an effective treatment?
The available research does not provide specific data on the effectiveness of the ENGAGE Intervention for Post-COVID Support in People With Disabilities. The studies mentioned focus on other treatments and approaches for post-COVID conditions, such as the REGAIN program and various rehabilitation strategies. Without direct data on ENGAGE, it's not possible to compare its effectiveness to other treatments based on the information provided.12345
What data supports the effectiveness of the ENGAGE treatment for post-COVID support in people with disabilities?
What safety data exists for the ENGAGE treatment for post-COVID support in people with disabilities?
The provided research does not contain specific safety data for the ENGAGE treatment or any related interventions for post-COVID support in people with disabilities. The studies focus on different support interventions during the COVID-19 pandemic, such as peer-based support in prisons, postdiagnostic dementia support, trends in drug-related deaths, managed alcohol programs for homelessness, and a bereavement support line. None of these directly evaluate the safety of the ENGAGE treatment.678910
Is the ENGAGE treatment a promising treatment for people with disabilities after COVID?
How is the ENGAGE treatment for post-COVID support in people with disabilities different from other treatments?
The ENGAGE treatment is unique because it focuses on peer support, which involves people with similar experiences helping each other, rather than just traditional medical approaches. This can be especially beneficial for those who are marginalized and may not access standard healthcare services, offering a more inclusive and community-based support system.111121314
Research Team
Joy Hammel, PhD
Principal Investigator
University of Illinois Chicago
Eligibility Criteria
This trial is for English-speaking individuals with disabilities who feel socially isolated, especially due to the pandemic. They must live in a community setting and be able to express their interest in participating verbally. People with severe communication impairments that limit this ability cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the ENGAGE intervention, which uses social learning, guided problem-solving, and applied skill training to promote social participation among people with disabilities
Follow-up
Participants are monitored for retention and adherence, with follow-up assessments to evaluate intervention feasibility and satisfaction
Treatment Details
Interventions
- ENGAGE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator